We are live on ! Find out more
TGI

TRV GP IV Portfolio holdings

AUM $267M
1-Year Est. Return 965.83%
This Fund
S&P 500
This Quarter Est. Return
+41.74%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
–
AUM
$217M
AUM Growth
+$108M
Cap. Flow
+$56.6M
Cap. Flow %
26.08%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PLRX icon
Pliant Therapeutics
PLRX
+$56.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
1
Pliant Therapeutics
PLRX
$64.4M
$69.2M 31.9%
+2,132,867
New +$56.6M
DNTH icon
2
Dianthus Therapeutics
DNTH
$5.84B
$60.1M 27.71%
500,513
– –
RVMD icon
3
Revolution Medicines
RVMD
$39.9B
$44.8M 20.65%
1,419,900
– –
FULC icon
4
Fulcrum Therapeutics
FULC
$273M
$42.9M 19.74%
2,343,154
– –

Similar funds

OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
WAM
Weinberger Asset Management Los Angeles, California $267M AUM 19.83% 1-Year Est. Return
IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
SIA
SGL Investment Advisors Missoula, Montana $266M AUM 18.29% 1-Year Est. Return
CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
EU
Emory University Atlanta, Georgia $267M AUM 48.26% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
ALC
Alexander Labrunerie & Co Columbia, Missouri $267M AUM 21.24% 1-Year Est. Return

TRV GP IV's Q2 2020 Portfolio in Review

As of Q2 2020, TRV GP IV held 4 positions worth $217M, up 98% from $109M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP IV deployed $56.6M of net new capital in Q2 2020, opening 1 new position. Its largest new stake was Pliant Therapeutics: 2,132,867 shares worth $69.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP IV's largest Q2 2020 buy was Pliant Therapeutics: 2,132,867 shares worth $69.2M.
  • TRV GP IV's ten largest holdings make up 100% of its $217M portfolio in Q2 2020.
  • TRV GP IV opened 1 new position and closed 0 in Q2 2020.
  • TRV GP IV's portfolio value rose 98% quarter-over-quarter to $217M.

Based on TRV GP IV's 13F filing for Q2 2020, filed 7 Aug 2020.